Navigation Links
IMRIS announces first IMRISneuro project in Australia
Date:1/6/2009

WINNIPEG, Jan. 6, 2009 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRIS" or the "Company") today announced it has secured its first order in Australia for its IMRISneuro surgical imaging solution, thereby expanding its presence in the Asia-Pacific region. The Canberra Hospital has chosen a two-room configuration of the IMRISneuro MR-guided intraoperative suite as part of a larger Australian Capital Territory infrastructure project.

IMRISneuro is a fully integrated operating room suite, including IMRIS' one-of-a-kind movable, high-field MRI. The new technology allows surgeons to safely image patients in the operating room during brain surgery, helping to rule out complications before the patient leaves the operating room.

"IMRIS continues its global expansion with this first order in Australia for IMRISneuro. This agreement provides further validation that IMRIS' powerful combination of products and people makes IMRISneuro the solution of choice for neurosurgeons around the world," said David Graves, President and CEO of IMRIS.

About IMRIS

IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical imaging solutions. The company's flagship product, IMRISneuro, utilizes patented technology that allows a high field MRI scanner to be moved in to the operating room on demand, providing imaging during the surgical procedure without compromising patient safety. This unique and innovative system has been validated by leading neurosurgeons for use in world-class neuroscience centers.

For more information, visit www.imris.com.


'/>"/>
SOURCE IMRIS Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. IMRISneuro: The iMRI technology of choice among the worlds top ranked hospitals
2. IMRISneuro at Central DuPage Hospital will be the first in the Chicago area
3. Dell Childrens Medical Center to install IMRISneuro in expanded neurocenter
4. Senior GE Executive to lead IMRIS Sales team in the U.S.
5. University of Virginia Health System invests in IMRISneuro, the next generation of surgical imaging technology
6. Providence St. Vincent bringing IMRISneuro, the worlds most advanced surgical MRI to Portland, Oregon
7. Akrimax Pharmaceuticals Announces Manufacturing Partnership
8. Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist.
9. American Asthma Foundation Announces Breakthrough Discovery
10. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
11. WellPoint Announces Innovative Program to Help Improve the Care of Members Suffering With Bipolar Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2017)... ... April 27, 2017 , ... Offering the purest product of ... many times purer and more potent than the market has seen before. Swissx uses ... as well as a patented chromatography process for extraction, to produce its CBD oil--maximizing ...
(Date:4/26/2017)... ... April 26, 2017 , ... Intalere, the healthcare ... podcast, “Make Plans for MACRA,” highlighting the impact of the Medicare ... and how physicians and other clinicians are reimbursed for the care they deliver ...
(Date:4/26/2017)... Aviv, Israel (PRWEB) , ... April 26, 2017 , ... ... today announced a new partnership with Med-e-Mass , the largest Electronic Medical Records ... enable Med-e-Mass to link care plan incentives to a patient’s remote health progress, empowering ...
(Date:4/26/2017)... Miami, FL (PRWEB) , ... April 26, 2017 , ... ... twenty-fifth anniversary as a dentist. , “I could have never imagined back in 1991 ... and personally,” said Dr. Gallardo. , Over the last 25 years, Dr. Gallardo has ...
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
(Date:4/18/2017)...  Cardinal Health (NYSE: CAH ) today ... per share (EPS) guidance and providing a preliminary view ... with this morning,s announcement of the planned acquisition of ... businesses. Cardinal Health now believes that fiscal ... the bottom of its previous guidance range of $5.35 ...
(Date:4/18/2017)... 2017 Viverae ® , a leader in ... of IBM ® Watson Campaign Automation, implementing behavioral ... for a personalized experience. Through digital engagement, the platform ... in real time. The enhanced experience drives engagement by ... wherever they are in their journey to health. ...
Breaking Medicine Technology: